+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Acute Lung Injury Treatment Market by Drug Class (Corticosteroids, Neuromuscular Blocking Agents, Surfactants), Administration Route (Inhalation, Intravenous), End User, Distribution Channel, Patient Age Group, Treatment Setting - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015132
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The acute lung injury treatment market is experiencing substantial transformation, driven by innovative therapeutic strategies, cross-disciplinary collaboration, and advanced health technologies. Senior executives are monitoring this space for solutions that balance clinical efficacy, operational resilience, and market adaptability.

Acute Lung Injury Treatment Market Snapshot

The Acute Lung Injury Treatment Market grew from USD 3.22 billion in 2024 to USD 3.36 billion in 2025. It is expected to continue growing at a CAGR of 4.20%, reaching USD 4.13 billion by 2030. This steady market expansion is informed by evolving clinical practices, global collaborative research, and the introduction of precision therapies. Acute lung injury is a complex clinical challenge, and new modalities from diagnostics to treatment delivery are reshaping care pathways for clinicians and providers globally.

Scope & Segmentation

  • Drug Classes: Corticosteroids (dexamethasone, hydrocortisone, methylprednisolone), neuromuscular blocking agents (cisatracurium, rocuronium, vecuronium), surfactants (beractant, poractant alfa), vasodilators (nitric oxide)
  • Administration Routes: Inhalation, intravenous
  • End Users: Ambulatory care centers, hospitals, research institutes
  • Distribution Channels: Hospital pharmacies (inpatient, outpatient), online pharmacies (direct to patient, third-party), retail pharmacies (chain, independent)
  • Patient Age Groups: Adult, geriatric, pediatric
  • Treatment Settings: Emergency departments, general wards, intensive care units
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, UAE, Saudi Arabia, South Africa, among others), Asia-Pacific (China, India, Japan, Australia, South Korea and more)
  • Leading Companies: Medtronic plc, Koninklijke Philips N.V., General Electric Company, Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Corporation Limited, Hamilton Medical AG, Smiths Group plc, Getinge AB, Vyaire Medical, Inc., Nihon Kohden Corporation
  • Technologies: AI diagnostics, real-world data analytics, advanced drug delivery systems, digital health monitoring, flexible bioprocessing, and ventilator innovation

Key Takeaways for Senior Decision-Makers

  • Pivotal advances in targeted pharmacotherapies and molecular diagnostics are enabling more personalized and effective acute lung injury management.
  • Integration of digital health tools and AI-driven analytics is improving early detection and intervention, supporting better patient outcomes and shortened critical care stays.
  • Strengthened collaborative research networks across academia, industry, and hospitals are accelerating knowledge transfer and the development of next-generation treatment protocols.
  • Adaptive supply chain strategies, including near-shoring and strategic warehousing, are being prioritized in response to shifting global trade landscapes.
  • Manufacturers are leveraging quality-by-design and flexible processing technologies to ensure consistency and scalability of key therapies.
  • Regional disparities in infrastructure and regulatory harmonization highlight the need for tailored commercial strategies and local partnerships.

Tariff Impact: Navigating Macroeconomic Challenges

The 2025 imposition of United States tariffs on imported active pharmaceutical ingredients has introduced new challenges for global supply chains. Healthcare providers and procurement leaders are observing intermittent shortages and higher costs for neuromuscular blocking agents and surfactants. In response, domestic manufacturing and alternative sourcing are expanding, while strategic partnerships and warehousing are being explored to maintain continuity of acute lung injury treatment access in a shifting policy environment.

Methodology & Data Sources

This analysis is based on a multi-stage market research process, combining reviews of peer-reviewed literature, clinical trial registries, regulatory filings, and expert interviews with stakeholders in pulmonology, critical care, and pharmaceutical development. Insights are validated with real-world data and input from industry advisory panels.

Why This Report Matters

  • Enables informed decision-making on investments, R&D directions, and market entry strategies by offering actionable analysis and robust segmentation frameworks.
  • Helps identify supply chain risks and emerging opportunities to foster operational resilience and long-term growth amidst regulatory and policy changes.

Conclusion

Innovation, collaboration, and adaptive operations are redefining the acute lung injury treatment landscape. Senior leaders can leverage these insights to drive progress and ensure flexible strategies for optimal patient care and market success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emerging biomarker-guided personalized therapies for acute lung injury management
5.2. Adoption of point-of-care ultrasound protocols to optimize fluid management in ALI patients
5.3. Clinical trial advancements in mesenchymal stem cell therapies targeting acute respiratory distress syndrome
5.4. Integration of AI-driven predictive analytics for early detection of acute lung injury risk
5.5. Regulatory approval pathways expediting novel inhaled anti-inflammatory agents for ALI
5.6. Implementation of tele-ICU platforms to support ventilator weaning strategies in acute lung injury
5.7. Development of extracorporeal carbon dioxide removal systems improving outcomes in severe ALI
5.8. Expansion of wearable biosensors for continuous respiratory monitoring in high-risk patients
5.9. Real-world evidence studies evaluating high-flow nasal cannula efficacy in moderate to severe ALI
5.10. Pharmaceutical collaborations focusing on lipid nanoparticle drug delivery for pulmonary inflammation
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Acute Lung Injury Treatment Market, by Drug Class
8.1. Introduction
8.2. Corticosteroids
8.2.1. Dexamethasone
8.2.2. Hydrocortisone
8.2.3. Methylprednisolone
8.3. Neuromuscular Blocking Agents
8.3.1. Cisatracurium
8.3.2. Rocuronium
8.3.3. Vecuronium
8.4. Surfactants
8.4.1. Beractant
8.4.2. Poractant Alfa
8.5. Vasodilators
8.5.1. Nitric Oxide
9. Acute Lung Injury Treatment Market, by Administration Route
9.1. Introduction
9.2. Inhalation
9.3. Intravenous
10. Acute Lung Injury Treatment Market, by End User
10.1. Introduction
10.2. Ambulatory Care Centers
10.3. Hospitals
10.4. Research Institutes
11. Acute Lung Injury Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.2.1. Inpatient Pharmacies
11.2.2. Outpatient Pharmacies
11.3. Online Pharmacies
11.3.1. Direct To Patient
11.3.2. Third Party Fulfillment
11.4. Retail Pharmacies
11.4.1. Chain Pharmacies
11.4.2. Independent Pharmacies
12. Acute Lung Injury Treatment Market, by Patient Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Acute Lung Injury Treatment Market, by Treatment Setting
13.1. Introduction
13.2. Emergency Department
13.3. General Ward
13.4. Intensive Care Unit
14. Americas Acute Lung Injury Treatment Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Acute Lung Injury Treatment Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Acute Lung Injury Treatment Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Medtronic plc
17.3.2. Koninklijke Philips N.V.
17.3.3. General Electric Company
17.3.4. Drägerwerk AG & Co. KGaA
17.3.5. Fisher & Paykel Healthcare Corporation Limited
17.3.6. Hamilton Medical AG
17.3.7. Smiths Group plc
17.3.8. Getinge AB
17.3.9. Vyaire Medical, Inc.
17.3.10. Nihon Kohden Corporation
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ACUTE LUNG INJURY TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ACUTE LUNG INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ACUTE LUNG INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ACUTE LUNG INJURY TREATMENT MARKET: RESEARCHAI
FIGURE 28. ACUTE LUNG INJURY TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 29. ACUTE LUNG INJURY TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 30. ACUTE LUNG INJURY TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ACUTE LUNG INJURY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY METHYLPREDNISOLONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY METHYLPREDNISOLONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CISATRACURIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CISATRACURIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ROCURONIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ROCURONIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VECURONIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VECURONIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY BERACTANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY BERACTANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PORACTANT ALFA, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PORACTANT ALFA, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NITRIC OXIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NITRIC OXIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY INPATIENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY INPATIENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY OUTPATIENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY OUTPATIENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY THIRD PARTY FULFILLMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY THIRD PARTY FULFILLMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY EMERGENCY DEPARTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY EMERGENCY DEPARTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY GENERAL WARD, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY GENERAL WARD, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY INTENSIVE CARE UNIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY INTENSIVE CARE UNIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 157. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 158. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 159. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 160. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 161. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2018-2024 (USD MILLION)
TABLE 162. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2025-2030 (USD MILLION)
TABLE 163. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2018-2024 (USD MILLION)
TABLE 164. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2025-2030 (USD MILLION)
TABLE 165. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2018-2024 (USD MILLION)
TABLE 166. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2025-2030 (USD MILLION)
TABLE 167. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 168. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 169. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 174. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 175. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 176. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 177. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 178. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 179. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 180. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 181. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 182. CANADA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 183. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 184. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 185. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2018-2024 (USD MILLION)
TABLE 188. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2025-2030 (USD MILLION)
TABLE 189. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2018-2024 (USD MILLION)
TABLE 192. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 194. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 195. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 200. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 201. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 202. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 203. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 204. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 205. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 206. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 207. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 208. MEXICO ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY NEUROMUSCULAR BLOCKING AGENTS, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY SURFACTANTS, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY VASODILATORS, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM ACUTE LUNG INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. UNI

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Acute Lung Injury Treatment market report include:
  • Medtronic plc
  • Koninklijke Philips N.V.
  • General Electric Company
  • Drägerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Corporation Limited
  • Hamilton Medical AG
  • Smiths Group plc
  • Getinge AB
  • Vyaire Medical, Inc.
  • Nihon Kohden Corporation

Table Information